Skip to main content
OpenTrials

Clinical trial condition

Cardiovascular Abnormalities

Explore clinical trials studying Cardiovascular Abnormalities. Study availability and eligibility vary by location and protocol.

1,876 public trials 356 recruiting studies
Refine in advanced search Browse all conditions

Cardiovascular Abnormalities trial results

Recruiting

Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases

NCT05329350

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +4 more
Locations
  • Children's Health Ireland Dublin, Ireland
  • İzmir Şehir Hastanesi Izmir, Bayraklı, Turkey (Türkiye)
  • Eskişehir Osmangazi Üniversite Hastanesi Eskişehir, Odunpazarı, Turkey (Türkiye)
  • Dicle Üniversitesi Tıp Fakültesi Hastanesi Diyarbakır, Sur, Turkey (Türkiye)
View Trial Details
Recruiting

GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

NCT03821129

Conditions
Brain Diseases, Cardiovascular Abnormalities, Cardiovascular Diseases, +13 more
Locations
  • St. Mary's Hospital Tucson, Arizona, United States
  • Scripps Health La Jolla La Jolla, California, United States
  • Loma Linda University Health Loma Linda, California, United States
  • University of California - San Francisco San Francisco, California, United States
View all 45 locations
View Trial Details
Recruiting

Post Marketing Clinical Follow Up Study to Evaluate Efficacy and Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

NCT05264753

Conditions
Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +5 more
Locations
  • CHU Sainte-Justine Montreal, Canada
  • CHU de Lille - Institut Cœur-Poumon Lille, France
  • Hôpital Mère Enfant, CHU de Nantes Nantes, France
  • Ospedale Pediatrico Bambino Gesù Roma, Italy
View all 15 locations
View Trial Details
Recruiting

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

NCT07221851

Conditions
Bone Diseases, Bone Diseases, Developmental, Cardiovascular Abnormalities, +32 more
Locations
  • Ascendis Pharma Investigational Site Palo Alto, California, United States
  • Ascendis Pharma Investigational Site Sacramento, California, United States
  • Ascendis Pharma Investigational Site Aurora, Colorado, United States
  • Ascendis Pharma Investigational Site Centennial, Colorado, United States
View all 34 locations
View Trial Details

Related conditions